Intrapleural Antimicrobial Irrigation for Postpneumonectomy Empyema in Patients With Lung Cancer

Author:

Torbic Heather1,Glasser Nicole2,Rostas Sara E.1,Alquwaizani Mohammed1,Hacobian Gaspar1

Affiliation:

1. Department of Pharmacy, Brigham and Women's Hospital, Boston, MA, USA

2. Department of Pharmacy, Crozer-Chester Medical Center, Upland, PA, USA

Abstract

Purpose: Postpneumonectomy empyema (PPE) is a possible complication after a pneumonectomy in patients with lung cancer. The use of intrapleural (IP) antibiotic irrigation to treat infections in the pleural space may be indicated after systemic antimicrobial therapy, and drainage of the pleural space has been insufficient. Methods: Adult patients ≥18 years old who received IP antibiotic irrigation between 2006 and 2011 were included. Demographic data, past medical history, surgical procedure, systemic antibiotics, and culture data were collected. Additionally, the IP antibiotic administered, the dose, and how it was prepared and administered were collected. Results: A total of 18 patients were evaluated in this retrospective descriptive analysis. The majority of patients underwent an extrapleural pneumonectomy (EPP; 72%). Most patients received systemic antibiotics before IP antibiotic administration (95%). Vancomycin was the most common antibiotic used for both systemic therapy (100%) and IP irrigation (94%). The median number of IP antibiotic doses received per patient was 5.5 (interquartile range [IQR] 1-9). Recurrence of PPE within 6 months of initial PPE resolution occurred in 28% of patients. Intrapleural antibiotic irrigation was well tolerated in all patients. Conclusion: Vancomycin is most commonly used for IP antibiotic irrigation at our institution after patients have undergone a thoracic surgery, which was most commonly an EPP.

Publisher

SAGE Publications

Subject

Pharmacology (medical)

Reference20 articles.

1. Cancer statistics, 2013

2. NCCN Small Cell Lung Cancer Guidelines. NCCN Guidelines Version 2.2013. National Comprehensive Cancer Network; Revised 2013.

3. NCCN Non-Small Cell Lung Cancer Guidelines. NCCN Guidelines Version 2.2013. National Comprehensive Cancer Network; Revised 2013.

4. NCCN Malignant Pleural Mesothelioma Cancer Guidelines. NCCN Guidelines Version 2.2013. National Comprehensive Cancer Network; Revised 2013.

5. Pneumonectomy: historical perspective and prospective insight

Cited by 9 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3